Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019
Limited data exist on mortality rates after tuberculosis (TB) treatment in the United States. We analyzed mortality rates for all adults in Georgia, USA, who had a TB diagnosis and finished treatment during January 1, 2008–December 31, 2019. We obtained posttreatment mortality rate data from the Na...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2024-11-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/30/11/24-0329_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850203123435438080 |
|---|---|
| author | Sarah Gorvetzian Antonio G. Pacheco Erin Anderson Susan M. Ray Marcos C. Schechter |
| author_facet | Sarah Gorvetzian Antonio G. Pacheco Erin Anderson Susan M. Ray Marcos C. Schechter |
| author_sort | Sarah Gorvetzian |
| collection | DOAJ |
| description |
Limited data exist on mortality rates after tuberculosis (TB) treatment in the United States. We analyzed mortality rates for all adults in Georgia, USA, who had a TB diagnosis and finished treatment during January 1, 2008–December 31, 2019. We obtained posttreatment mortality rate data from the National Death Index and calculated standardized mortality ratios (SMRs) for TB treatment survivors and the general Georgia population. Among 3,182 TB treatment survivors, 233 (7.3%) had died as of December 31, 2019. The overall TB cohort age- and sex-adjusted SMR was 0.89 (95% CI 0.73–1.05). The SMR among US-born TB treatment survivors was 1.56 (95% CI 1.36–1.77). In the TB cohort, US-born status, HIV co-infection, excess alcohol use, diabetes mellitus, and end-stage renal disease were associated with increased risk for death after TB treatment. TB treatment survivors could benefit from improved linkage to primary and HIV comprehensive care to prevent posttreatment death.
|
| format | Article |
| id | doaj-art-26c62f4cb7794ed9bd9e6b438fce58d8 |
| institution | OA Journals |
| issn | 1080-6040 1080-6059 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj-art-26c62f4cb7794ed9bd9e6b438fce58d82025-08-20T02:11:35ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592024-11-0130112261227010.3201/eid3011.240329Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019Sarah GorvetzianAntonio G. PachecoErin AndersonSusan M. RayMarcos C. Schechter Limited data exist on mortality rates after tuberculosis (TB) treatment in the United States. We analyzed mortality rates for all adults in Georgia, USA, who had a TB diagnosis and finished treatment during January 1, 2008–December 31, 2019. We obtained posttreatment mortality rate data from the National Death Index and calculated standardized mortality ratios (SMRs) for TB treatment survivors and the general Georgia population. Among 3,182 TB treatment survivors, 233 (7.3%) had died as of December 31, 2019. The overall TB cohort age- and sex-adjusted SMR was 0.89 (95% CI 0.73–1.05). The SMR among US-born TB treatment survivors was 1.56 (95% CI 1.36–1.77). In the TB cohort, US-born status, HIV co-infection, excess alcohol use, diabetes mellitus, and end-stage renal disease were associated with increased risk for death after TB treatment. TB treatment survivors could benefit from improved linkage to primary and HIV comprehensive care to prevent posttreatment death. https://wwwnc.cdc.gov/eid/article/30/11/24-0329_articletuberculosismortalityHIVbacteriaHIV/AIDS and other retrovirusesrespiratory infections |
| spellingShingle | Sarah Gorvetzian Antonio G. Pacheco Erin Anderson Susan M. Ray Marcos C. Schechter Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 Emerging Infectious Diseases tuberculosis mortality HIV bacteria HIV/AIDS and other retroviruses respiratory infections |
| title | Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 |
| title_full | Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 |
| title_fullStr | Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 |
| title_full_unstemmed | Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 |
| title_short | Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019 |
| title_sort | mortality rates after tuberculosis treatment georgia usa 2008 2019 |
| topic | tuberculosis mortality HIV bacteria HIV/AIDS and other retroviruses respiratory infections |
| url | https://wwwnc.cdc.gov/eid/article/30/11/24-0329_article |
| work_keys_str_mv | AT sarahgorvetzian mortalityratesaftertuberculosistreatmentgeorgiausa20082019 AT antoniogpacheco mortalityratesaftertuberculosistreatmentgeorgiausa20082019 AT erinanderson mortalityratesaftertuberculosistreatmentgeorgiausa20082019 AT susanmray mortalityratesaftertuberculosistreatmentgeorgiausa20082019 AT marcoscschechter mortalityratesaftertuberculosistreatmentgeorgiausa20082019 |